This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Mike Mitka

JAMA. 2001;285:1950-1951.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Orlando, Fla—Researchers at the Annual Scientific Session of the American College of Cardiology (ACC) said sildenafil (Viagra, Pfizer Inc, New York, NY) apparently does not increase the risk of heart attack and that improved sexual function associated with the drug may be enhanced by its effects on the heart and blood vessels.

But some pharmacoepidemiologists, although encouraged by the safety study, warn that the findings are not definitive.

Sildenafil has been prescribed for more than 10 million men worldwide since being approved by the US Food and Drug Administration (FDA) in March 1998 and by the European Commission that September. According to Pfizer Inc, more than 300 million tablets have been dispensed in more than 100 countries.

Although sildenafil has been a boon to men with erectile dysfunction (ED), a few men have died after taking the drug. The unanswered question is whether such deaths are caused . . . [Full Text of this Article]